Koji Ikeda
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Top Wall Street analysts see robust growth potential in these 3 stocks
The latest earnings season has eased concerns about a potential artificial intelligence bubble. Increased spending by hyperscalers and other companies has reinforced confidence in the demand for AI infrastructure and software solutions. Investors keen on capitalizing on the AI boom can track recommendations from top Wall Street analysts, who give key insights into a company's ability to capture AI-driven demand despite macro uncertainties and rising competition.
Doctors thought this kidney drug helped some patients. It may help millions more.
Doctors thought this kidney drug helped some patients. It may help millions more. - Date: - June 8, 2026